1. Home
  2. JAGX vs SBEV Comparison

JAGX vs SBEV Comparison

Compare JAGX & SBEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • SBEV
  • Stock Information
  • Founded
  • JAGX 2013
  • SBEV 1992
  • Country
  • JAGX United States
  • SBEV United States
  • Employees
  • JAGX N/A
  • SBEV N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • SBEV Beverages (Production/Distribution)
  • Sector
  • JAGX Health Care
  • SBEV Consumer Staples
  • Exchange
  • JAGX Nasdaq
  • SBEV Nasdaq
  • Market Cap
  • JAGX 12.9M
  • SBEV 11.4M
  • IPO Year
  • JAGX N/A
  • SBEV N/A
  • Fundamental
  • Price
  • JAGX $0.85
  • SBEV $0.22
  • Analyst Decision
  • JAGX
  • SBEV Strong Buy
  • Analyst Count
  • JAGX 0
  • SBEV 2
  • Target Price
  • JAGX N/A
  • SBEV $0.75
  • AVG Volume (30 Days)
  • JAGX 542.5K
  • SBEV 5.3M
  • Earning Date
  • JAGX 11-13-2024
  • SBEV 11-15-2024
  • Dividend Yield
  • JAGX N/A
  • SBEV N/A
  • EPS Growth
  • JAGX N/A
  • SBEV N/A
  • EPS
  • JAGX N/A
  • SBEV N/A
  • Revenue
  • JAGX $10,480,000.00
  • SBEV $6,257,725.00
  • Revenue This Year
  • JAGX $18.18
  • SBEV N/A
  • Revenue Next Year
  • JAGX $40.06
  • SBEV $95.41
  • P/E Ratio
  • JAGX N/A
  • SBEV N/A
  • Revenue Growth
  • JAGX N/A
  • SBEV N/A
  • 52 Week Low
  • JAGX $0.84
  • SBEV $0.14
  • 52 Week High
  • JAGX $21.60
  • SBEV $0.73
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 39.11
  • SBEV 55.47
  • Support Level
  • JAGX $0.84
  • SBEV $0.18
  • Resistance Level
  • JAGX $1.33
  • SBEV $0.23
  • Average True Range (ATR)
  • JAGX 0.10
  • SBEV 0.04
  • MACD
  • JAGX -0.03
  • SBEV 0.00
  • Stochastic Oscillator
  • JAGX 1.04
  • SBEV 32.65

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About SBEV Splash Beverage Group Inc. (NV)

Splash Beverage Group Inc is a portfolio company managing multiple brands across several growth segments within the consumer beverage industry. The company's two reportable operating segments are: (1) the manufacture and distribution of non-alcoholic and alcoholic beverages, and (2) the retail sale of beverages and groceries online. The company generates the majority of its revenue from the E-Commerce segment. Qplash is a wholly owned division of Splash. It is the company's first entry point into the e-commerce channel. For beverage-alcohol products, the company operate within what is referred to as a "Three Tier Distribution System" where manufacturers are not permitted to sell directly to retailers, but instead, contract for local and regional distribution with independent distributors.

Share on Social Networks: